Register for email alerts and news feeds:
This journal | BMJ Group
rss
Annals of the Rheumatic Diseases 2003;62:497-498; doi:10.1136/ard.62.6.497
Copyright © 2003 BMJ Publishing Group Ltd & European League Against Rheumatism.
Annals of the Rheumatic Diseases 2003;62:497-498
© 2003 by BMJ Publishing Group & European League Against Rheumatism

LEADER

Hypouricaemia

Fenofibrate and losartan

T Bardin

Fédération de Rhumatologie, Hôpital lariboisiére, 2 rue Ambroise Paré, 75010 Paris, France

Correspondence to:
Correspondence to:
Professor T Bardin;
thomas.bardin@lrb.ap-hop-paris.fr


Should we take advantage of their uricosuric properties in clinical practice?

Keywords: losartan; fenofibrate; uric acid; hypertension; hypertriglyceridaemia

The first 150 words of the full text of this article appear below.

The interesting study published in this issue of the journal by Takahashi et al sheds light on two drugs, losartan and fenofibrate, which have hypouricaemic properties, in addition to their main therapeutic effects.1

LOSARTAN

Losartan potassium is an orally active angiotensin II receptor antagonist used for the treatment of hypertension. This product and its long life metabolite E-3174 are potent antagonists at the AT1 receptor. The observation that losartan increases urinary uric acid excretion and reduces serum uric acid level was first made in a pilot study conducted in healthy subjects and published in 1992. Uric acid fractional clearance was mainly increased during the first four hours after drug intake in a time course consistent with a direct effect of the drug. The increase was found to be dose dependent and to persist after seven days of administration.2 Angiotensin is known to lower uric acid renal clearance,3 but the uricosuric . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Daskalopoulou, S S, Mikhailidis, D P, Athyros, V G, Papageorgiou, A A, Elisaf, M (2004). Fenofibrate and losartan. Ann Rheum Dis 63: 469-470 [Full Text]  
  • (2003). Robin Goodfellow (42-8). Rheumatology (Oxford) 42: 1028-1028 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs